Hubei Jumpcan Pharmaceutical Co., Ltd.

600566

CNE0000018X6

HUBEI JUMPCAN PHARMACEUTICAL CO., LTD., formerly Hubei Hongcheng General Machinery Co., Ltd., is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The Company's products include heat-clearing and detoxifying series, digestive system series, pediatric series, breathing series, cardiovascular series and gynecology series. Its pharmaceuticals consist of tablets, mixtures, injections, capsules, granules and sprays, among others. The Company mainly distributes its products within domestic markets.

Sector

Pharmaceuticals

Calendar

2024-04-19 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for Hubei Jumpcan Pharmaceutical Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

43.96 CNY

Average target price

52.36 CNY

Spread / Average Target

+19.11%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	+39.87%	5.6B
ELI LILLY AND COMPANY	+24.16%	672B
NOVO NORDISK A/S	+24.08%	550B
JOHNSON & JOHNSON	-5.95%	351B
MERCK & CO., INC.	+15.15%	317B
ABBVIE INC.	+6.68%	292B
ASTRAZENECA PLC	+3.26%	211B
NOVARTIS AG	+0.78%	203B
PFIZER, INC.	-10.18%	144B
AMGEN INC.	-7.20%	141B

Other Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-18 pm EDT			5-day change	1st Jan Change
43.96 ^CNY	0.00%		+5.52%	+39.87%

10:52am	Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 09	Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04:52am	CI
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 09	CI
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	Apr. 02	CI
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	Jan. 02	CI
Jumpcan Pharma Registers Two New Drugs	Nov. 02	MT
Hubei Jumpcan Pharma’s Q3 Profit Jumps 4.8%, Revenue Falls 6%	23-10-23	MT
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-22	CI
Nanjing Zenshine Pharmaceuticals Co., Ltd. announced that it has received CNY 100 million in funding from Hubei Jumpcan Pharmaceutical Co., Ltd., Kunlun Capital, Zhejiang Saizhi Bole Equity Investment Management Co., Ltd, Zhongshan Zhonghui Investment Group Co.,ltd.	23-10-12	CI
Tranche Update on Hubei Jumpcan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 4, 2023.	23-10-09	CI
Nanjing Zenshine Pharmaceuticals Co., Ltd. announced that it expects to receive CNY 60 million in funding from Hubei Jumpcan Pharmaceutical Co., Ltd.	23-09-17	CI
Hubei Jumpcan Pharma Registers Oral Solution to Treat ADHD	23-09-12	MT
Hubei Jumpcan Pharma Logs Double-Digit Earnings Growth in H1 on Strong Sales, Reduced Costs; Shares Jump 5%	23-08-14	MT
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-13	CI
Hubei Jumpcan Pharmaceutical Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	23-07-03	CI
Hubei Jumpcan Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	23-07-02	CI
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-17	CI
Hubei Jumpcan Pharma to Apply For Up to 2 Billion Yuan Loan in 2023	23-04-10	MT
China's Weibo ups stake in Inmyshow Digital with $315 million acquisition	23-03-01	RE
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-01-19	CI
Rating Agency Ends Rating Hubei Jumpcan Pharmaceutical's Bonds	22-11-18	MT
Hubei Jumpcan Pharmaceutical Ties Up with Hengyi Biomedical for Product Development	22-11-07	MT
Hubei Jumpcan Pharmaceutical’s Q3 Profit Rises 38% as Revenue Jumps 18%; Shares Up 5%	22-10-24	MT
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-20	CI
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-19	CI
Hubei Jumpcan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-22	CI